Judge Richard G. Andrews recently denied plaintiff Novartis Pharmaceuticals Corporation’s unopposed motion to seal the transcript of a court conference. Novartis Pharmaceuticals Corporation, et al. v. Actavis South Atlantic LLC, et al., C.A. No. 11-1077-RGA (consol.) (D. Del. Mar. 10, 2014). In the Court’s view, the portions of the transcript that Novartis requested the Court seal, “reflect[ed], at most, that Novartis engages in typical settlement discussions, which everybody in the pharmaceutical industry already must know.” Id. Because Judge Andrews did not find that the disclosure of the information would harm Novartis’s business, Judge Andrews denied the unopposed motion. Id.
Delaware IP Law Blog 